drugset / Trial / NCT05696678
Improving ObsQoR-11 With Continuous Wound Infusion Versus Intrathecal Morphine After Elective Cesarean Delivery
Withdrawn
Ciusss de L'Est de l'Île de Montréal
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this prospective randomized double-blinded and controlled study is to evaluate the quality of recovery after elective cesarean delivery using the Obstetric Quality-of-Recovery-11 (ObsQoR-11) score at 24 hours between patients receiving intrathecal morphine (ITM group) compared to patients receiving a ropivacaine continuous wound infusion (CWI group).
Timeline
- Start
- 2023-02
- Primary completion
- 2023-08
- Completion
- 2023-11
Outcome
Outcome not reported
Stopped: “The PI has permanently left the institution”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Morphine | Other / unclassified | 100 ug | Intrathecal |
| Comparator | Ropivacaine | Other / unclassified | 0.2 % | Other |
Indications
No indication recorded.